BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang L, Zou ZQ, Wang K. Clinical Relevance of HLA Gene Variants in HBV Infection. J Immunol Res. 2016;2016:9069375. [PMID: 27243039 DOI: 10.1155/2016/9069375] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Xu T, Zhu A, Sun M, Lv J, Qian Z, Wang X, Wang T, Wang H. Quantitative assessment of HLA-DQ gene polymorphisms with the development of hepatitis B virus infection, clearance, liver cirrhosis, and hepatocellular carcinoma. Oncotarget 2018;9:96-109. [PMID: 29416599 DOI: 10.18632/oncotarget.22941] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
2 Trinks J, Marciano S, Esposito I, Franco A, Mascardi MF, Mendizabal M, Livellara B, Arrigo D, Calzetta P, Vujacich C, Giunta D, Gadano A, Flichman D. The genetic variability of hepatitis B virus subgenotype F1b precore/core gene is related to the outcome of the acute infection. Virus Res 2020;277:197840. [PMID: 31846615 DOI: 10.1016/j.virusres.2019.197840] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Tandoh KZ, Kusi KA, Archampong TN, Boamah I, Quaye O. Hepatitis B infection outcome is associated with novel human leukocyte antigen variants in Ghanaian cohort. Exp Biol Med (Maywood) 2020;245:815-22. [PMID: 32349537 DOI: 10.1177/1535370220921118] [Reference Citation Analysis]
4 Cilião Alves DC, Haddad R, Rocha-Júnior MC, de Deus Wagatsuma VM, Martelli-Palomino G, Marques AA, Takayanagui OM, Covas DT, Kashima S, Donadi EA. HLA-G 3'-untranslated region polymorphisms are associated with HTLV-1 infection, proviral load and HTLV-associated myelopathy/tropical spastic paraparesis development. J Gen Virol 2016;97:2742-52. [PMID: 27449667 DOI: 10.1099/jgv.0.000559] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
5 Wolf JM, Simon D, Lunge VR. Hepatitis B virus genotypes in Brazil: Introduction and dissemination. Infect Genet Evol 2021;93:104936. [PMID: 34023512 DOI: 10.1016/j.meegid.2021.104936] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Namgoong S, Shin JG, Cheong HS, Kim LH, Kim JO, Seo JY, Shin HD, Kim YJ. Genetic association of complement component 2 variants with chronic hepatitis B in a Korean population. Liver Int 2018;38:1576-82. [PMID: 29283494 DOI: 10.1111/liv.13675] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ding Y, Zhou Z, Li X, Zhao C, Jin X, Liu X, Wu Y, Mei X, Li J, Qiu J, Shen C. Screening and Identification of HBV Epitopes Restricted by Multiple Prevalent HLA-A Allotypes. Front Immunol 2022;13:847105. [PMID: 35464415 DOI: 10.3389/fimmu.2022.847105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Van Hees S, Chi H, Hansen B, Bourgeois S, Van Vlierberghe H, Sersté T, Francque S, Wong D, Sprengers D, Moreno C, Nevens F, Janssen H, Vanwolleghem T. Caucasian Ethnicity, but Not Treatment Cessation is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg Seroconversion. Viruses 2019;11:E687. [PMID: 31357522 DOI: 10.3390/v11080687] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
9 Liu B, Shao Y, Fu R. Current research status of HLA in immune-related diseases. Immun Inflamm Dis 2021;9:340-50. [PMID: 33657268 DOI: 10.1002/iid3.416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Xu T, Sun M, Wang H. Relationship between HLA-DQ Gene Polymorphism and Hepatitis B Virus Infection. Biomed Res Int 2017;2017:9679843. [PMID: 28512640 DOI: 10.1155/2017/9679843] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
11 Van Hees S, Bourgeois S, Van Vlierberghe H, Sersté T, Francque S, Michielsen P, Sprengers D, Reynaert H, Henrion J, Negrin Dastis S, Delwaide J, Lasser L, Decaestecker J, Orlent H, Janssens F, Robaeys G, Colle I, Stärkel P, Moreno C, Nevens F, Vanwolleghem T; Belgian NA Stop Study Group. Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes. Aliment Pharmacol Ther 2018;47:1170-80. [PMID: 29498078 DOI: 10.1111/apt.14560] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
12 Medhasi S, Chantratita N, Ciccacci C. Human Leukocyte Antigen (HLA) System: Genetics and Association with Bacterial and Viral Infections. Journal of Immunology Research 2022;2022:1-15. [DOI: 10.1155/2022/9710376] [Reference Citation Analysis]
13 Velkov S, Protzer U, Michler T. Global Occurrence of Clinically Relevant Hepatitis B Virus Variants as Found by Analysis of Publicly Available Sequencing Data. Viruses 2020;12:E1344. [PMID: 33238650 DOI: 10.3390/v12111344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhang Z, Wang C, Liu Z, Zou G, Li J, Lu M. Host Genetic Determinants of Hepatitis B Virus Infection. Front Genet. 2019;10:696. [PMID: 31475028 DOI: 10.3389/fgene.2019.00696] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
15 Wang J, Du L, Tang H. Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection. Front Med (Lausanne) 2021;8:784172. [PMID: 34901094 DOI: 10.3389/fmed.2021.784172] [Reference Citation Analysis]
16 Jin X, Ding Y, Sun S, Wang X, Zhou Z, Liu X, Li M, Chen X, Shen A, Wu Y, Liu B, Zhang J, Li J, Yang Y, Qiu H, Shen C, He Y, Zhao G. Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8+ T cell responses in HLA-A transgenic mice. Cell Mol Immunol 2021. [PMID: 34728796 DOI: 10.1038/s41423-021-00784-8] [Reference Citation Analysis]
17 Lv J, Xu T, Qian Z, Wang H. Association between HLA-DQ Gene Polymorphisms and HBV-Related Hepatocellular Carcinoma. Gastroenterol Res Pract 2017;2017:7150386. [PMID: 28761441 DOI: 10.1155/2017/7150386] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
18 Akcay IM, Katrinli S, Ozdil K, Doganay GD, Doganay L. Host genetic factors affecting hepatitis B infection outcomes: Insights from genome-wide association studies. World J Gastroenterol 2018; 24(30): 3347-3360 [PMID: 30122875 DOI: 10.3748/wjg.v24.i30.3347] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
19 Lumley SF, McNaughton AL, Klenerman P, Lythgoe KA, Matthews PC. Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen. Front Immunol 2018;9:1561. [PMID: 30061882 DOI: 10.3389/fimmu.2018.01561] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
20 Wu Y, Ding Y, Shen C. A Systematic Review of T Cell Epitopes Defined from the Proteome of Hepatitis B Virus. Vaccines 2022;10:257. [DOI: 10.3390/vaccines10020257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Choga WT, Anderson M, Zumbika E, Phinius BB, Mbangiwa T, Bhebhe LN, Baruti K, Kimathi PO, Seatla KK, Musonda RM, Bell TG, Moyo S, Blackard JT, Gaseitsiwe S. In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana. Viruses 2020;12:E731. [PMID: 32640609 DOI: 10.3390/v12070731] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Mei X, Li X, Zhao C, Liu A, Ding Y, Shen C, Li J. The Use of Molecular Dynamics Simulation Method to Quantitatively Evaluate the Affinity between HBV Antigen T Cell Epitope Peptides and HLA-A Molecules. Int J Mol Sci 2022;23:4629. [PMID: 35563019 DOI: 10.3390/ijms23094629] [Reference Citation Analysis]
23 Liu WC, Wu IC, Chiu YC, Tseng KC, Chen CY, Chiu HC, Cheng PN, Chang TT. Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patients. Antiviral Res 2020;176:104719. [PMID: 32004619 DOI: 10.1016/j.antiviral.2020.104719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Liu Q, Shi Z, Liu X, Xiao H. Correlation between the coexpression of zinc finger and SCAN domain-containing protein 31 and transcriptional activator with PDZ-binding motif and prognosis in hepatocellular carcinoma. Ann Transl Med 2020;8:1308. [PMID: 33209888 DOI: 10.21037/atm-20-6373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Guan Y, Feng M, Min X, Zhou H, Fu Y, Tachibana H, Cheng X. Characteristics of inflammatory reactions during development of liver abscess in hamsters inoculated with Entamoeba nuttalli. PLoS Negl Trop Dis 2018;12:e0006216. [PMID: 29420539 DOI: 10.1371/journal.pntd.0006216] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
26 Pistono C, Osera C, Boiocchi C, Mallucci G, Cuccia M, Bergamaschi R, Pascale A. What's new about oral treatments in Multiple Sclerosis? Immunogenetics still under question. Pharmacol Res 2017;120:279-93. [PMID: 28396093 DOI: 10.1016/j.phrs.2017.03.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]